Composition
- Active ingredients
- APIXABAN 0.15MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- APIXABAN 0.5MG · Tablet, for suspensionNDA202155-003 · Prescription
- APIXABAN 2.5MG · TabletNDA202155-001 · Prescription
- APIXABAN 5MG · TabletNDA202155-002 · Prescription
- APIXABAN 0.15MG · SuspensionThis page
- APIXABAN 5MG · TabletNDA220073-002 · Prescription
- APIXABAN 0.5MG · TabletNDA220073-003 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA220073.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Eliquis
- Active substance
- apixaban
- Route
- Oral
- Dosage form
- Suspension
- Applicant
- Bristol
- Status
- Prescription
- FDA approval
- 17 Apr 2025
- Application
- NDA220073-004